Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06629233
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
Evaluation of a Novel Technique for the Discovery of New Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Tn-Miner Technology for the Discovery of Tumor-specific Glycopeptide Immunotherapy Targets
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Tn-Miner
Brief Summary:
The goal of this interventional prospective research on human bodily material is to discover new cancer-specific molecular structures ie glycopeptides within surgically removed estrogen receptor positive breast cancer tumors
The main goal it aims to achieve is
To discover tumor-specific targets that allow the use of very potent immunotherapeutic drugs as treatment for solid tumors such as estrogen receptor positive breast cancer These new targets are very specific for cancer cells meaning that virtually no healthy cells should be attacked by the treatment resulting in less side effects
Participants will undergo standard of care treatment comprising surgical removal of the breast tumor Part of these tissues will be used for this clinical research
The main goal it aims to achieve is
To discover tumor-specific targets that allow the use of very potent immunotherapeutic drugs as treatment for solid tumors such as estrogen receptor positive breast cancer These new targets are very specific for cancer cells meaning that virtually no healthy cells should be attacked by the treatment resulting in less side effects
Participants will undergo standard of care treatment comprising surgical removal of the breast tumor Part of these tissues will be used for this clinical research
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None